SUGAR LAND, Texas (AP) — SUGAR LAND, Texas (AP) — Tvardi Therapeutics, Inc. (TVRD) on Thursday reported second-quarter net income of $4.2 million.
On a per-share basis, the Sugar Land, Texas-based company said it had net loss of $1.
The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 51 cents per share.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TVRD at https://www.zacks.com/ap/TVRD
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
